Imricor Medical Systems (ASX:IMR) FFO per Share


ASX:IMR Imricor Medical Systems Inc ASX:IMR
47 GF Score
Price A$1.99
GF Value A$0.10
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Imricor Medical Systems FFO per Share?

FFO per Share only applies to REITs.

ASX:IMR
47GF Score
Imricor Medical Systems Inc ASX:IMR
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Imricor Medical Systems (ASX:IMR) Overvalued in 2026?

Based on GuruFocus' analysis, Imricor Medical Systems stock appears to be overvalued. The current stock price of A$1.99 is trading 1890% above its estimated GF Value™ of A$0.10. GuruFocus considers Imricor Medical Systems to be Significantly Overvalued.

Key valuation signals for ASX:IMR:

  • FFO per Share:
  • GF Value™: A$0.10 vs. price of A$1.99 (1890% above fair value)
  • GF Score™: 47/100 with 10 warning signs

No single metric tells the full story. See the ASX:IMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Imricor Medical Systems Business Description

Address 400 Gateway Boulevard, Burnsville, MN, USA, 55337
Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe.
47GF Score

Get the complete analysis for ASX:IMR

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.99
Price
A$0.10
GF Value